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ABSTRACT 
Background: COVID-19 affecting the outcome of pregnancy is still under 
investigation. Here we report a case of primigravida with monochorionic diamniotic 
twin pregnancy with superimposed preeclampsia who develop symptoms of COVID-
19 infection on her near term pregnancy and was confirmed later on as COVID-19 
positive after cesarean section. The pregnancy was terminated abdominally due to 
the intrauterine fetal demise of both twins using COVID-19 standard equipment. 
Case Presentation: A 29-year-old female, gravida 1, para 0 presented with a twin 
pregnancy at the gestational age of 36 weeks was referred to our emergency 
department for further management of intrauterine fetal death of both twins. Six days 
before admitted to our emergency department, she has been experienced a remittent 
fever which followed by a mild cough. Four days before admission, she complained 
of decrease movement of the babies. She went to the Secondary Hospital to check 
her pregnancy and both fetal heart rates were not found.  The patient is obese (BMI 
49.2 kg/m2) and had prior uncontrolled hypertension but no other medical history, 
including epilepsy, allergies, asthma, heart disease as well as Diabetes Mellitus. 
Conclusion: A research about placental pathology in pregnancy with confirmed 
case of COVID-19 infection showed no pathognomonic feature in the histopathologic 
examination but mostly, there were maternal vascular malperfusion (decidual 
arteriopathy in particular) and intervillous thrombi. In the end, a further examination 
is suggested to evaluate the course and causal factors pertaining to this case. 
 






COVID-19 is currently a global pandemic. Due 
to the high level of virus spread, pregnant women 
as populations at risk need special attention. 
However, data related to the outcome of pregnant 
women with COVID-19 positive are still limited. 
Pregnant women with preeclampsia are 
included in high-risk pregnancies. The risk of 
preeclampsia can increase in conditions of multiple 
pregnancies, as well as a previous history of high 
blood pressure in patients. In addition, 
accumulating evidence reveals that hypertension is 
an adverse comorbid condition for COVID-19 
infection.  
In this report, we present a case of stillbirth 
babies in the twin pregnancy complicated with 
superimposed pregnancy who was subsequently 
confirmed to be COVID-19 positive.  
 
 
2. Case Presentation 
A 29-year-old female, gravida 1, para 0 presented 
with a twin pregnancy at the gestational age of 36 
weeks was referred to our emergency department for 
further management of intrauterine fetal death of both 
twins. Six days before admitted to our emergency 
department, she has been experienced a remittent 
fever which followed by a mild cough. Four days 
before admission, she complained of decrease 
movement of the babies. She went to the Secondary 
Hospital to check her pregnancy and both fetal heart 
rates were not found.  The patient is obese (BMI 49.2 
kg/m2) and had prior uncontrolled hypertension but 
no other 
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medical history, including epilepsy, allergies, 
asthma, heart disease as well as Diabetes Mellitus. 
However, her blood pressure during routine antenatal 
care in the secondary Hospital was controlled using 
single drug alpha methyldopa and her twin were 
growing accordingly despite her medical history. The 
patient denied any impending eclampsia symptoms 
such as headache, epigastric pain, nausea, and blurry 
vision. Due to her fever history, the patient was 
performed thoracic X-ray which showed non-specific 
infiltrate on both lungs suggesting 
bronchopneumonia. She was then referred to our 
hospital for further management.  
Upon arrival, her vital sign was as follow; 
blood pressure of 160/100 mmHg, heart rate of 88 
bpm, respiration rate 20 times per minutes (99% O2 
peripheral saturation) and temperature of 36.8o C. 
During the clinical examination, it was found that 
the patient was still not in labor with cervical 
dilation of 2 cm and inadequate contractions. She 
was further screened for COVID-19 status using 
routine Early Warning Score checklist form (Table 
1) and she was assessed as People at Risk (ODR: 
Orang Dalam Risiko) or low suspected COVID-19.
 
Transabdominal ultrasonography (TAUS) 
revealed that both fetuses were in breech 
presentation, both were absent of fetal movement, 
heart movement, and heart rate.  
The fetuses presented with 2525 and 2945 grams 
of estimated fetal weight for first and second fetus 
respectively. Further, there is a bulkhead in the 
amniotic sacs which giving an impression of 
monochorionic-diamniotic twin with the single 
deepest pocket of amniotic fluid of 8.91 cm. There 
was also found Spalding sign on both fetuses 
suggesting intrauterine fetal death. Placenta was 
implanted in the fundus, without expansion to the 
internal uterine ostium nor separation and rounding 
of placental edge. 
Her laboratory data showed a white blood cell 
count of 10,400/μL, hemoglobin level of 10,8 g/dL, 
hematocrit of 33,4%, platelet count of 268.000/μL, 
blood glucose of 116 mg/dL, prothrombin time of 
12.4 sec, activated partial thromboplastin time of 29.9 
sec, aspartate aminotransferase level of 19 U/L, 
alanine transaminase level of 10 U/L, blood urea 
nitrogen level of 17 mg/dl and creatinine of 0.9 
mg/dl, lactate dehydrogenase of 306 U/L. The urine 
protein level was 100 mg/dL.  
She was administered magnesium sulfate 20% 
injection (1 gram/ hour on syringe pump), as well as 
antihypertensive agents (calcium channel blocker 
10mg every 8 hours and alpha methyldopa 500mg 
every 8 hours). To prevent the worsening of the 
mother, an emergency caesarean section was 
performed using level 3 personal protective 
equipment. The infants (both female) were delivered 
weighing 1400 and 2700 grams for the first and 
second baby respectively, with an Apgar score of 0 
and grade II maceration. The placenta showed no 
evidence of abruption such as infarct or hematoma. 
Her blood pressure returned to normal (110/70 
mmHg) right after the emergency procedure and she 
was admitted to the isolation room.  
Day-1 following Caesarean Section, the 
patient’s blood pressure was 130/80 mmHg, and 
heart rate of 88 bpm. However, she developed 
another fever with a temperature of 37.6o C which 
Table 1. COVID-19 Early Warning Score1 
Parameters Assessment Finding Score 
Signs of pneumonia on CT Yes not assessed 0 
History of close contact with 
COVID-19 confirmed patient Yes No 0 
Fever Yes No 0 
Age > 44 years old 29 years old 0 
Sex Male Female 0 
Tmax > 37,8°C (or 100°F) No 0 
Meaningful respiratory symptoms 
(including cough, expectoration, 
and dyspnea > 1 symptom No 0 
NLR > 5.8 2.92 0 
Total score     0 
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accompanied the complaint of dyspnea (respiration 
rate was 22 times per minute). Auscultation of the 
lungs revealed crackles on both sides but no 
wheezing was heard. Later, she was then consulted to 
The Internal Medicine Department and Microbiology 
Department to get the COVID-19 assessment done. 
She was performed nasopharyngeal swab, re-
evaluated for the chest X-ray, and blood was drawn 
for the differential count.  
 
  
Figure 1. The chest X-ray of the patient showed no 
infiltration on the lungs. 
 
In the mean-time, she was given Oxygen via nasal 
cannula (3 litres per minute), antihypertensive drugs 
(calcium channel blocker 10 mg every 8 hours and 
alpha methyldopa 500 mg every 8 hours), vitamins 
(B complex, vitamin C and Sulfas Ferrous 1 tablet 
every 12 hours), dopamine-agonist (bromocriptine 
2.5mg every 8 hours) and intravenous antibiotic 
(levofloxacin 750 mg every 24 hours). Her 
subsequent chest X-ray showed no sign of 
bronchopneumonia (figure 1), the differential count 
of white blood cells was as follows; eosinophil 0%, 
basophil 0%, segmented-neutrophil 73%, 
lymphocyte 25%, and monocyte 1% (NLR of 2.92).  
Day-3 following the Cesarean section, the 
patient’s vital sign was improved with the blood 
pressure of 130/80 mmHg, heart rate 98 bpm, the 
respiration rate of 20 times per minute, and 
temperature of 37oC. She was discharged on the 3rd 
day post-operation according to clinical practice in 
the hospital. One week after discharge, her swab test 
was positive for COVID-19. She was then admitted 
to the District Hospital for isolation and treatment 
with current stable conditions. 
 
3. Discussion 
SARS-CoV2 virus or novel Coronavirus is 
single-stranded RNA, non-segmented, enveloped 
viruses, which cause a wide range of illnesses from 
the common cold to severe disease. Since the 
emergence of this virus, there is little data on adverse 
pregnancy outcomes in pregnant women with 
COVID-192,3. Previous studies on other 
coronaviruses (SARS-CoV and MERS-CoV) 
proposed that pregnancy poses a higher risk of severe 
illness, morbidity, and mortality compared with the 
general population2. However, to our knowledge, 
there has been no case report that describes the 
stillbirth of near-term, twin pregnancy complicated 
with symptomatic COVID-19 infection. 
Viral pneumonia has been described as an 
important cause of morbidity and mortality during 
pregnancy. It is associated with adverse obstetrical 
outcomes, such as premature rupture of membranes 
(PROM) and preterm labor (PTL), intrauterine fetal 
demise (IUFD), intrauterine growth restriction 
(IUGR) as well as neonatal death 3. However, it is 
not evident that these outcomes were related to 
maternal infection, and the risk of adverse infant 
outcomes is still obscure2,3. Currently, very limited 
is known about COVID-19 related to its effect on 
pregnancy and neonatal period. Furthermore, there 
are no specific recommendations for pregnant 
women regarding the evaluation or management of 
COVID-19. 
It has been suggested that twin gestations have a 
higher risk for prospective IUFD4.  Furthermore, 
monochorionic twin gestations have higher rates of 
stillbirth than either dichorionic twin or singleton 
gestations5. This is attributed primarily to placental 
vascular complications such as twin to twin 
transfusion syndrome. Other factors include selective 
growth restriction, maternal obstetric complications 
as well as co-twin death due to intravascular shunting 
after a single intrauterine death6. A study involved a 
total of 454,626 twins showed that stillbirth was 
observed in 1585 fetuses (0.35%) overall. However, 
the risk of fetal demise was statistically significant 
only between 37 and 38 weeks’ gestation4. 
Additionally, a study on 768 twins showed the 
prospective risk of IUFD at ≥ 34 weeks’ gestation 
was 0% and 0.17% for monochorionic and 
dichorionic twins respectively5. 
Regarding hypertensive disorders during 
pregnancy, the risk of stillbirth in singleton 
pregnancy was significantly higher than in 
normotensive women7,8.  In contrast, in multifetal 
pregnancy, stillbirth was generally not significantly 
associated with hypertensive disorders. With only 
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superimposed preeclampsia was associated with a 
significantly increased risk of stillbirth by 1.95 fold 
overall8. Furthermore, this increase was observed 
only at ≤ 28 weeks’ gestation and at 28 to 31 weeks’ 
gestation8. 
Owing to the findings of our patient who 
developed superimposed preeclampsia at a near term 
pregnancy (36 weeks), the possibility that twin fetal 
demise was due to complications of COVID-19 is 
still open on the table. However, there is no 
histopathologic examination of the placental tissue 
that might be responsible to be the cause of the 
complication to this pregnancy. A research about 
placental pathology in pregnancy with confirmed 
case of COVID-19 infection showed no 
pathognomonic feature in the histopathologic 
examination but mostly, there were maternal vascular 
malperfusion (decidual arteriopathy in particular) and 
intervillous thrombi.9 In the end, a further 
examination is suggested to evaluate the course and 
causal factors pertaining to this case.  
Limitation 
This study had limitation due to there were no further 
examination of the demised babies such as 
pathological and RT PCR to rule out the vertical 
transmission of COVID-19. 
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